These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14718356)

  • 41. Ethnicity affects vasodilation, but not endothelial tissue plasminogen activator release, in response to bradykinin.
    Rosenbaum DA; Pretorius M; Gainer JV; Byrne D; Murphey LJ; Painter CA; Vaughan DE; Brown NJ
    Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):1023-8. PubMed ID: 12067915
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interactive Effect of Ethnicity and ACE Insertion/Deletion Polymorphism on Vascular Reactivity.
    Gainer JV; Stein CM; Neal T; Vaughan DE; Brown NJ
    Hypertension; 2001 Jan; 37(1):46-51. PubMed ID: 11208755
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exogenous nitric oxide increases basal leg glucose uptake in humans.
    Durham WJ; Yeckel CW; Miller SL; Gore DC; Wolfe RR
    Metabolism; 2003 Jun; 52(6):662-5. PubMed ID: 12800088
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The hypotensive effect of L-arginine is associated with increased expired nitric oxide in humans.
    Mehta S; Stewart DJ; Levy RD
    Chest; 1996 Jun; 109(6):1550-5. PubMed ID: 8769510
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polymorphisms in urea cycle enzyme genes are associated with persistent pulmonary hypertension of the newborn.
    Kaluarachchi DC; Smith CJ; Klein JM; Murray JC; Dagle JM; Ryckman KK
    Pediatr Res; 2018 Jan; 83(1-1):142-147. PubMed ID: 28609431
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel Pathogenic Variant (c.580C>T) in the CPS1 Gene in a Newborn With Carbamoyl Phosphate Synthetase 1 Deficiency Identified by Whole Exome Sequencing.
    Choi R; Park HD; Yang M; Ki CS; Lee SY; Kim JW; Song J; Chang YS; Park WS
    Ann Lab Med; 2017 Jan; 37(1):58-62. PubMed ID: 27834067
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polymorphisms in the transcription factor NRF2 and forearm vasodilator responses in humans.
    Marczak ED; Marzec J; Zeldin DC; Kleeberger SR; Brown NJ; Pretorius M; Lee CR
    Pharmacogenet Genomics; 2012 Aug; 22(8):620-8. PubMed ID: 22668754
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeting CPS1 in the treatment of Carbamoyl phosphate synthetase 1 (CPS1) deficiency, a urea cycle disorder.
    Diez-Fernandez C; Häberle J
    Expert Opin Ther Targets; 2017 Apr; 21(4):391-399. PubMed ID: 28281899
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence for in vivo transport of bioactive nitric oxide in human plasma.
    Rassaf T; Preik M; Kleinbongard P; Lauer T; Heiss C; Strauer BE; Feelisch M; Kelm M
    J Clin Invest; 2002 May; 109(9):1241-8. PubMed ID: 11994413
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic use of carbamylglutamate in the case of carbamoyl-phosphate synthetase deficiency.
    Kuchler G; Rabier D; Poggi-Travert F; Meyer-Gast D; Bardet J; Drouin V; Cadoudal M; Saudubray JM
    J Inherit Metab Dis; 1996; 19(2):220-2. PubMed ID: 8739970
    [No Abstract]   [Full Text] [Related]  

  • 51. Molecular characterization of carbamoyl-phosphate synthetase (CPS1) deficiency using human recombinant CPS1 as a key tool.
    Diez-Fernandez C; Martínez AI; Pekkala S; Barcelona B; Pérez-Arellano I; Guadalajara AM; Summar M; Cervera J; Rubio V
    Hum Mutat; 2013 Aug; 34(8):1149-59. PubMed ID: 23649895
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of total body urea production potential with total body carbamoyl phosphate synthetase (CPS-1) activity in newborn piglets infused with alanine at 50% of resting energy expenditure for 36 hours.
    Davis JA; Greer FR; Benevenga NJ
    J Nutr; 2000 Aug; 130(8):1978-83. PubMed ID: 10917911
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Two novel CPS1 mutations in a case of carbamoyl phosphate synthetase 1 deficiency causing hyperammonemia and leukodystrophy.
    Chen X; Yuan L; Sun M; Liu Q; Wu Y
    J Clin Lab Anal; 2018 Jun; 32(5):e22375. PubMed ID: 29314318
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Detection of CPS1 gene mutation in a neonate with carbamoyl phosphate synthetase I deficiency].
    Zhang H; Lang Y; Zhang K; Li X; Liu Y; Gai Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Dec; 35(6):848-851. PubMed ID: 30512161
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional role of nitric oxide in regulation of ocular blood flow.
    Koss MC
    Eur J Pharmacol; 1999 Jun; 374(2):161-74. PubMed ID: 10422757
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The bradykinin type 2 receptor BE1 polymorphism and ethnicity influence systolic blood pressure and vascular resistance.
    Pretorius MM; Gainer JV; Van Guilder GP; Coelho EB; Luther JM; Fong P; Rosenbaum DD; Malave HA; Yu C; Ritchie MD; Vaughan DE; Brown NJ
    Clin Pharmacol Ther; 2008 Jan; 83(1):122-9. PubMed ID: 17522594
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Split AAV-Mediated Gene Therapy Restores Ureagenesis in a Murine Model of Carbamoyl Phosphate Synthetase 1 Deficiency.
    Nitzahn M; Allegri G; Khoja S; Truong B; Makris G; Häberle J; Lipshutz GS
    Mol Ther; 2020 Jul; 28(7):1717-1730. PubMed ID: 32359471
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma kallikrein-bradykinin pathway promotes circulatory nitric oxide metabolite availability during hypoxia.
    Padhy G; Gangwar A; Sharma M; Himashree G; Singh K; Bhaumik G; Bhargava K; Sethy NK
    Nitric Oxide; 2016 May; 55-56():36-44. PubMed ID: 26952290
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and genetic analysis of a case of late onset carbamoyl phosphate synthase I deficiency caused by CPS1 mutation and literature review.
    Wang S; Chen J; Zhu X; Huang T; Xu H; Ying G; Qian H; Lin W; Tung Y; Khan KU; Guo H; Zheng G; Lu H; Zhang G
    BMC Med Genomics; 2023 Jun; 16(1):145. PubMed ID: 37365635
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Variant in the allosteric domain of CPS1 protein associated with effectiveness of N-carbamoyl glutamate therapy in neonatal onset CPS1 deficiency.
    Gragnaniello V; Gueraldi D; Puma A; Commone A; Loro C; Cazzorla C; Häberle J; Burlina AB
    J Pediatr Endocrinol Metab; 2023 Sep; 36(9):873-878. PubMed ID: 37427576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.